approval · primary record
NAPROXEN
FDA · NDA · 2024-11-21
| Agency | FDA |
|---|---|
| Submission type | NDA |
| Action date | 2024-11-21 |
| Brand | NAPROSYN |
| Sponsor | ATNAHS PHARMA US |
| Route | ORAL |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-28T02:34:28.521Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: FDA:NAPROXEN:2024-11-21
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.